Health ❯Cancer ❯Melanoma

Immunotherapy

Treatment Keytruda Surgery Patient Experiences Treatment Updates Genetic Research Stage Four

Inherited Mitochondrial Variant Linked to Checkpoint Inhibitor Resistance in Metastatic Melanoma

NYU Langone Health researchers link the HG-T variant to weakened T cell responses with plans to test haplogroup-guided immunotherapy.

Teddi Mellencamp Faces Stage 4 Melanoma with 50/50 Survival Odds

Teddi Mellencamp Faces Stage 4 Cancer with 50/50 Survival Odds

FDA Approves Groundbreaking Cellular Therapy for Advanced Melanoma

Teddi Mellencamp Undergoes Major Surgery in Ongoing Skin Cancer Battle

Merck-Moderna Vaccine Reduces Risk of Severe Melanoma Relapse by Half